Table 1.
Sample sets utilised in the study
| Number of samples | Origin | Subgroups | Sequencing method | |
|---|---|---|---|---|
| Sample set 1 | 55 | Prostatectomy specimens of non-treated cancer, transurethral resection specimens of locally recurrent CRPC and BPH specimens obtained by several methods | BPH (12), PC (30), locally recurrent CRPC (13) | Whole genome and whole transcriptome/HiSeq |
| Sample set 2 | 80 | Prostatectomy specimens of non-treated cancer, lymph node metastases collected during lymphadenectomy, metastatic CRPC specimens and noncancerous control specimens collected from 30 individuals at autopsy | PC (24), lymph node metastasis (8), metastatic CRPC (30), noncancerous control (18) | SureSelect targeted DNA and targeted RNA/MiSeq |
BPH benign prostatic hyperplasia, PC prostate cancer, CRPC castration-resistant prostate cancer